Zhengye Biotechnology Holdings Inc. | Small-cap | Healthcare
$6.34
-13.03%
| Zhengye Stock Comparison:
Zhengye vs ZoetisZhengye vs Haleon Plc - ADRZhengye vs SupernusZhengye vs Indivior PLCZhengye vs Bausch HealthZhengye vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2023

Income Metrics

Revenue 211.7M
Gross Profit 129.9M 61.35%
Operating Income 57.7M 27.26%
Net Income 37.5M 17.72%

Balance Sheet Metrics

Total Assets 499.9M
Total Liabilities 160.6M
Shareholders Equity 339.3M
Debt to Equity 0.47

Cash Flow Metrics

Operating Cash Flow 50.8M
Free Cash Flow 36.6M

Revenue & Profitability Trend

Zhengye Income Statement From 2021 to 2023

Metric 2023 2022 2021
Revenue 211.7M 260.3M 214.1M
Cost of Goods Sold 81.8M 106.8M 88.7M
Gross Profit 129.9M 153.5M 125.4M
Operating Expenses 72.2M 86.5M 69.8M
Operating Income 57.7M 67.1M 55.6M
Pre-tax Income 43.8M 63.9M 53.1M
Income Tax 6.3M 8.2M 6.6M
Net Income 37.5M 55.7M 46.5M
EPS (Diluted) - - -

Income Statement Trend

Zhengye Balance Sheet From 2021 to 2023

Metric 2023 2022 2021
Assets
Current Assets 205.6M 214.3M 164.9M
Non-Current Assets 294.3M 305.4M 280.3M
Total Assets 499.9M 519.7M 445.3M
Liabilities
Current Liabilities 150.2M 152.2M 125.6M
Non-Current Liabilities 10.4M 10.6M 816.0K
Total Liabilities 160.6M 162.8M 126.4M
Equity
Total Shareholders Equity 339.3M 356.9M 318.8M

Balance Sheet Composition

Zhengye Cash Flow Statement From 2021 to 2023

Metric 2023 2022 2021
Operating Activities
Net Income 37.5M 55.7M 46.5M
Operating Cash Flow 50.8M 4.2M 27.7M
Investing Activities
Capital Expenditures -6.3M -27.3M -18.9M
Investing Cash Flow -7.6M -27.3M -18.9M
Financing Activities
Dividends Paid -39.5M -21.4M -11.0M
Financing Cash Flow -19.0M 13.5M -3.0M
Free Cash Flow 36.6M -10.0M 5.4M

Cash Flow Trend

Zhengye Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 125.50
Price to Book 1.22
Price to Sales 1.88

Profitability Ratios

Profit Margin 10.69%
Operating Margin 15.71%
Return on Equity 7.15%
Return on Assets 3.82%

Financial Health

Current Ratio 1.38
Debt to Equity 24.98

Per Share Data

EPS (TTM) $0.06
Book Value per Share $6.17
Revenue per Share $4.16

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
zybt 356.9M 125.50 1.22 7.15% 10.69% 24.98
Zoetis 70.3B 28.34 15.12 52.09% 27.12% 145.63
Haleon Plc - ADR 47.2B 25.01 5.88 8.95% 12.84% 63.41
Supernus 1.8B 28.53 1.72 6.32% 9.27% 3.13
Indivior PLC 1.7B 530.50 -6.04 -0.57% -5.30% -1.29
Bausch Health 2.3B -47.00 -9.23 14.29% -0.41% -89.63

Financial data is updated regularly. All figures are in the company's reporting currency.